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Abstract Objective: To assess the
incidence and outcome of clinically
significant aspiration pneumonitis in
intensive care unit (ICU) overdose
patients and to identify its predispos-
ing factors. Design: Retrospective
cohort study. Setting: Medical ICU
of an academic tertiary care hospital.
Patients: A total of 273 consecutive
overdose admissions. Measurements
and results: Clinically significant
aspiration pneumonitis was defined
as the occurrence of respiratory dys-
function in a patient with a localised
infiltrate on chest X-ray within 72 h of
admission. In our cohort we identified
47 patients (17%) with aspiration
pneumonitis. Importantly, aspiration
pneumonitis was associated with
a higher incidence of cardiac arrest
(6.4 vs 0.9%; p = 0.037) and an in-
creased duration of both ICU stay and
overall hospital stay [respectively:
median 1 (interquartile range 1–3) vs
1 (1–2), p = 0.025; and median 2 (1–7)
vs 1 (1–3), p < 0.001]. In multivariate
logistic regression analysis, Glasgow
Coma Scale (GCS) score [odds ratio
(OR) for each point of GCS 0.8;
95% confidence interval (CI) 0.7–0.9;
p = 0.001], ingestion of opiates (OR
4.5; 95% CI 1.7–11.6; p = 0.002), and
white blood cell count (WBC) (OR
for each increase in WBC of 109/l
1.05; 95% CI 1.0–1.19; p = 0.049)
were identified as independent risk
factors. Conclusions: Clinically
relevant aspiration pneumonitis is
a frequent complication in over-
dose patients admitted to the ICU.
Moreover, aspiration pneumonitis is
associated with a higher incidence of
cardiac arrest and increased ICU and
total in-hospital stay.
Keywords Aspiration · Pneumonitis ·
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Introduction
Drug overdose is an important and increasingly fre-
quent cause of admission to the ICU, and accounts for
significant morbidity and mortality [1, 2, 3]. In 2001,
approximately 15.9 million Americans had used an illicit
drug at least once in the month prior to being inter-
viewed [2]. Moreover, hospital use due to overdose has
increased. Mortality rate was 3.9% in a recent report of
patients with acute poisoning admitted to the emergency
department [3].
Aspiration pneumonitis (AP) is a common com-
plication of drug overdose [2, 4, 5]. AP results from
the aspiration of gastric contents, which causes acute
chemical inflammation and shows a broad spectrum
of clinical outcomes, ranging from asymptomatic and
self-limiting episodes to the development of severe
pneumonitis with rapid progression to acute respiratory
distress syndrome [6, 7]. Bacterial colonisation leading to
aspiration pneumonia and sepsis are uncommon sequelae,
although in severe cases they may occur.
There are only few studies of aspiration in overdose
patients, and most focus on the risk of aspiration with gas-
tric emptying [5]. In addition, overlap between the clinical
entities of AP and aspiration pneumonia complicates
epidemiological and clinical studies of AP. Therefore,
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little is known about the incidence and risk factors of
AP [6]. This study sought to determine the frequency and
outcome of clinically significant AP in an ICU population
of overdose patients, and to identify its predisposing
factors.
Materials and methods
Setting and study population
We performed a retrospective observational study in con-
secutive overdose patients admitted to the medical ICU of
the University Hospital Basel, Switzerland, within a 3-year
period. AP was recorded as the primary endpoint. Manage-
ment in general included repetitive administrations of ac-
tivated charcoal [8]. Gastric emptying was not performed
in any of the patients. Prospective data collection was ap-
proved by the local ethics committee and was in accor-
dance with the principles of the Declaration of Helsinki.
Endpoints
Clinically significant AP was defined as the occurrence of
respiratory dysfunction in a patient with a localised pul-
monary infiltrate on chest X-ray [5]. Chest X-ray was rou-
tinely performed in this cohort. All patients with an obvi-
ous or at least suspected local infiltrate were identified as
potential cases and therefore reviewed for significant respi-
ratory dysfunction. Respiratory dysfunction was defined as
at least one of the following: invasive or non-invasive me-
chanical ventilation for hypoxaemia or hypercapnia, sup-
plemental oxygen > 4 l/min; respiratory rate > 20/min, ar-
terial oxygen saturation < 92%, PaO2 < 10 kPa within the
first 72 h after admission.
We identified ingested drugs using ambulance charts,
history, urine screening and blood analysis. Patients were
contacted 6 months after discharge by telephone.
Statistical analysis
Results are expressed as means ± SD for continuous
normally distributed variables. For non-parametric data,
medians with interquartile ranges are used. To describe
baseline characteristics, comparisons were made us-
ing the t-test, Mann–Whitney U-test, Fisher’s exact
test and chi-square test as appropriate. Univariate and
multivariate analyses were conducted using logistic
regression. The following variables were entered in
multivariate analysis: Glasgow Coma Scale (GCS) score
on admission, opiate ingestion, APACHE II, heart rate
on admittance, serum sodium, serum potassium, white
blood cell count (WBC). Risk-adjusted mortality rates
(observed/expected) were compared for patients with
and without AP, using the diagnostic category weight of
drug overdose for the expected rates [9, 10]. Tests were
two-sided, and a p value of less than 0.05 was considered
to indicate statistical significance. Statistical analyses
were performed using SPSS/PC (version 12.0, SPSS
Inc.).
Results
Between January 1998 and August 2001, of a total of 3499
ICU patients 273 were admitted for intoxication. Using the
predefined criteria, 61 patients (22%) showed a localised
infiltrate on chest X-ray. Of these, 47 (17%) additionally
had respiratory dysfunction. Thus, a total of 47 patients
(17%; 95% CI 13–22%) met the criteria for clinical rele-
vant AP. As shown in Table 1, there were important dif-
ferences among baseline characteristics in patients with
and without AP. Values are given as median (interquartile
range), if not otherwise indicated.
The GCS score on admittance of patients with AP was
7 (3–9), compared with 14 (7–15) in patients without AP.
Sixty-one per cent of all patients (167 of 273) had a GCS
score of 14 or less, 26% (70 of 273) a GCS score of less
than 8. APACHE II score was significantly higher in pa-
tients with AP than in patients without (Table 1).
Mixed drug intoxication was present in most patients.
Ingestion of opiates was identified in 38% of patients with
AP and only in 12% of those without. Other substances
were ingested in similar frequency by patients with and
without AP.
Outcome
A total of 7 patients (2.6%) died during the hospitalisa-
tion, with similar risk-adjusted mortality rates in patients
with and without AP. The high O/E ratios are caused
by the chosen diagnostic category weight of drug over-
dose, which leads to relatively low expected mortality
rates.
The length of stay was significantly longer in patients
with AP than in patients without AP, both in the ICU and
overall in hospital. Three patients with AP suffered a car-
diac arrest (6.4%) while in the ICU, against two patients
without AP (0.9%; p = 0.037). There were no deaths dur-
ing the 6-month follow-up period.
Risk factor analyses for aspiration pneumonitis
Several predictors of AP could be identified in univariate
logistic regression (Table 2). Of these, GCS score on ad-
mittance, opiate ingestion, and WBC remained statistically
significant independent predictors of AP in multivariate lo-
gistic regression.
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Table 1 Baseline characteristics and outcome
All overdose patients Aspiration pneumonitis
Yes No p Value
n = 273 (100) n = 47 (17) n = 226 (83)
Age, years, median (IQR) 37 (29–47) 39 (34–48) 36 (28–46) 0.066
Sex 0.126
Female, n (%) 172 (63) 25 (53) 147 (65)
Male, n (%) 101 (37) 22 (47) 79 (35)
Before admission
Cardiac arrest, n (%) 3 (1.1) 1 (2.1) 2 (0.9) 0.434
Seizure, n (%) 11 (4) 4 (8.5) 7 (3.1) 0.101
Arrhythmia, n (%) 7 (2.6) 2 (4.3) 5 (2.2) 0.346
On admission
GCS, median (IQR) 13 (7–15) 7 (3–9) 14 (9–15) < 0.001
APACHE II score, median (IQR) 8 (5–14) 15 (10–18) 7 (4–12) < 0.001
Heart rate, per minute, median (IQR) 90 (76–105) 104 (77–119) 88 (75–100) 0.013
Systolic blood pressure, mmHg, mean ± SD 122 ± 22 117 ± 23 123 ± 22 0.161
Serum sodium, mmol/l, median (IQR) 139 (137–142) 139 (136–142) 139 (137–142) 0.321
Serum potassium, mmol/l, median (IQR) 3.7 (3.5–4.1) 3.9 (3.6–4.3) 3.7 (3.5–4.0) 0.018
White blood cell count, 109/l, median (IQR) 8.6 (6.8–11.2) 9.9 (7.1–14.9) 8.4 (6.7–10.7) 0.008
Ingested drugs (incl. co-ingestion)
Cyclic antidepressants, n (%) 76 (28) 18 (38) 58 (26) 0.079
SSRI, n (%) 28 (10) 4 (9) 24 (11) 0.796
Neuroleptics, n (%) 51 (19) 6 (13) 45 (20) 0.253
Benzodiazepines, n (%) 130 (48) 27 (57) 103 (46) 0.138
Alcohol, n (%) 60 (22) 8 (17) 52 (23) 0.367
Opiates, n (%) 45 (17) 18 (38) 27 (12) < 0.001
Cocaine, n (%) 16 (6) 5 (11) 11 (5) 0.164
Other sedative, n (%) 43 (16) 7 (15) 36 (16) 0.859
Paracetamol, n (%) 15 (6) 2 (4) 13 (6) 1.000
Others, n (%) 96 (35) 11 (23) 85 (38) 0.063
Ventilation
Non-invasive ventilation, n (%) 6 (2.2) 6 (13) 0 (0) < 0.001
Mechanical ventilation, n (%) 29 (11) 22 (47) 7 (3) < 0.001
Outcome
Cardiac arrest, n (%) 5 (1.8) 3 (6.4) 2 (0.9) 0.037
Seizure, n (%) 14 (5.1) 4 (8.5) 10 (4.4) 0.272
Arrhythmia, n (%) 17 (6.2) 5 (10.6) 12 (5.3) 0.184
Death during hospitalisation, n (%) 7 (2.6) 2 (4.3) 5 (2.2) 0.346
Predicted hospital mortality (%) 0.7 1.1 0.6 < 0.001
Observer/expected ratio of mortality (95% CI) 3.8 (1.5, 7.7) 3.8 (0.5, 12.9) 3.8 (1.2, 8.7) 0.998
Length of stay in ICU, days, median (IQR) 1 (1–2) 1 (1–3) 1 (1–2) 0.025
Length of stay in hospital, days, median (IQR) 1 (1–3) 2 (1–7) 1 (1–3) < 0.001
GCS, Glasgow Coma Scale score [14]; APACHE II, Acute Physiologic and Chronic Health Evaluation II [9]
Variable Odds ratio 95% Confidence p Value
interval
Univariate analysis
GCS on admittance (continuous) 0.81 0.75–0.87 < 0.001
Opiate ingestion 4.58 2.24–9.33 < 0.001
APACHE II (continuous) 1.17 1.10–1.24 < 0.001
Heart rate on admittance (per minute) 1.02 1.00–1.03 0.027
(continuous)
Serum sodium (mmol/l) (continuous) 0.94 0.88–1.00 0.039
Serum potassium (mmol/l) (continuous) 1.81 1.17–2.81 0.008
White blood cell count (109/l) (continuous) 1.11 1.04–1.19 0.002
Multivariate analysis
GCS on admittance (continuous) 0.83 0.75–0.93 0.001
Opiate ingestion 4.50 1.74–11.60 0.002
White blood cell count (109/l) (continuous) 1.05 1.00–1.19 0.049
Continuous variables: odds ratios (OR) for each increase of one unit of the respective variable. For in-
stance, a patient with a GCS of 15 on admittance has an OR of 0.81 for aspiration pneumonitis compared
with a patient with a GCS of 14
Table 2 Predictors of aspiration
pneumonitis in univariate and
multivariate analyses
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Discussion
This study shows that clinically relevant AP is a frequent
complication in an unselected cohort of consecutive over-
dose patients admitted to the ICU. In addition, AP was as-
sociated with an increased length of stay in the ICU and in
hospital, and a higher incidence of cardiac arrest. GCS on
admittance, ingestion of opiates, and WBC were identified
as readily definable independent risk factors for AP.
The incidence of AP in our population is within the
wide range found in previous studies. Differences in the
types of drugs abused, ICU admission strategies, incidence
of risk factors and definition of clinical significant AP
seem to account for most of the difference in incidence.
Isbister and colleagues reported a frequency of AP of 11%
in unselected overdose patients admitted to the ICU in
Australia [5]. In a study of the relation between GCS score
and the incidence of AP, the rate of AP in overdose patients
admitted to the ICU was 29% [11]. A GCS score of 14 or
less was present in 85% of patients in that study, compared
with 61% in our study. Since deeper unconsciousness as
indicated by a lower GCS score is associated with a higher
risk of aspiration, the difference in GCS score may well
be responsible for the different incidence of AP in the two
studies. Also, a high incidence of AP of 28% was found in
a Finnish population [12]. In that cohort, 68% of patients
were unconscious, with unconsciousness defined as a GCS
score of 3–7. In contrast, only 26% of our patients had
a GCS score of 3–7. Again, the difference in the level of
consciousness between the two populations might account
for the different frequency of AP.
In our study, AP was associated with significantly in-
creased morbidity: patients with AP had longer LOS both
in the ICU and in hospital. This finding is supported by re-
cent data from Australia [5]. In addition, our study shows
that patients with AP have a higher rate of cardiac arrest.
Mortality overall was low in our cohort. Therefore we had
limited statistical power to investigate the impact of AP
on mortality. In our cohort, risk-adjusted mortality rates
showed no differences between patients with AP and with-
out. Isbister and colleagues reported significantly greater
overall mortality in patients with AP than in patients with-
out AP in a very large overdose population [5].
Given the clinically significant increased morbidity in
patients with AP, it is mandatory to identify easily and
rapidly assessable risk factors for AP. Our study clearly
shows the important role of the GCS score, the ingestion of
opiates and an increased WBC as independent predictors
for AP. All three risk factors are easily available during the
initial assessment in the ICU and therefore very useful in
clinical practice. Differences in baseline patient character-
istics, study setting, and definition of clinically significant
AP may account for the difference in independent predic-
tors found in previous studies [5, 12]. Additional prospec-
tive studies are necessary to validate the risk factors found
in our study.
Several limitations apply to our study: firstly, our
definition of AP may have included some patients with
early aspiration pneumonia. Although the identification of
secondary bacterial colonisation and infection is difficult,
the rate of this complication was low, at most, as we
included only patients with infiltration and respiratory
dysfunction within 72 h after the admission. Infectious
complications in general become clinically apparent only
after several days of pulmonary aspiration. Secondly,
it is possible that in our study some patients had other
pulmonary complications of opiate intoxication rather
than AP [2]. Particularly heroin can cause pulmonary
oedema. Using a localised infiltrate on chest X-ray as in-
clusion criterion for AP should have excluded most cases
of pulmonary oedema, since heroin-induced pulmonary
oedema manifests typically as widespread, bilateral
airspace consolidation on chest X-ray [13].
In conclusion, relevant AP is a frequent complication
of overdose patients admitted to the ICU. Three readily
assessable variables identify patients at risk for AP. This
is clinically important, as AP is associated with increased
morbidity.
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